Nitib 140 mg (Ibrutinib)

Nitib 140 mg treats CLL, MCL, and blood cancers. Trusted BTK-targeted therapy for long-term care.

pack size Price Add to Cart
30 Capsules - USD $8.00 / Capsule$240.00
View Cart
60 Capsules - USD $7.33 / Capsule$440.00
View Cart
90 Capsules - USD $7.11 / Capsule$640.00
View Cart

Nitib 140 mg (Ibrutinib)

Active IngredientIbrutinib
Indication:Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Manufacturer:Hetero Drugs Ltd
Packaging30 capsules in 1 bottle
Strength140mg
Delivery Time6 To 15 days

Nitib 140 mg contains Ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor used in treating certain blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma, and Waldenström’s macroglobulinemia. It blocks cancer cell signals that cause growth and division. Nitib is taken orally once daily, often as part of long-term targeted therapy. Common side effects include diarrhea, fatigue, bruising, or infections. Serious risks include heart rhythm issues and bleeding. Regular blood tests and ECG monitoring may be needed. Always take under oncologist supervision. Do not skip or stop without medical guidance.

pack size

30 Capsules – USD $8.00 / Capsule, 60 Capsules – USD $7.33 / Capsule, 90 Capsules – USD $7.11 / Capsule

There are no reviews yet.

Be the first to review “Nitib 140 mg (Ibrutinib)”